Scientists uncover how two drugs team up to fight sleep apnea
NCT ID NCT05944965
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how two drugs, atomoxetine and oxybutynin, affect throat muscles in people with obstructive sleep apnea (OSA). The goal was to understand why the combination works better than either drug alone. 27 adults with OSA took part, and researchers measured muscle activity during sleep. The findings help explain the mechanism behind this potential new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Womens Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Freezing away sleep apnea: a new procedure targets throat fat to open the airway
- Could a sleep apnea machine keep heart patients out of the hospital?
- Nerve zap in the neck could replace CPAP for sleep apnea
- Can a smartwatch and app boost CPAP use in heart patients?
- New implant could help sleep apnea patients ditch the CPAP mask
- Sleep apnea treatment may also help your mouth and swallowing